CLINICAL_TRIALS
trial_result
· 2025-03-17
Clinical Trial Update: A Study of LY3561774 in Participants With Mixed Dyslipidemia [Phase 2]
Summary
Phase 2 study of LY3561774 in participants with mixed dyslipidemia completed; trial results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Dyslipidemias, Lipid Metabolism Disorders | Phase 2 | Status: COMPLETED | Results posted: 2025-03-17